PainReform Ltd. (PRFX) vs Redhill Biopharma Ltd. (RDHL)
- PainReform Ltd. PRFX 0.81 −4.71%
- Redhill Biopharma Ltd. RDHL 0.48 −4.00%
PainReform Ltd. and Redhill Biopharma Ltd. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. is the larger, with a market value of $4.4M against $2.6M — 1.7× the size. Redhill Biopharma Ltd. has the higher net margin (25.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 7 metrics below, Redhill Biopharma Ltd. leads on 4 and PainReform Ltd. on 3.
Valuation
| Metric | PRFX | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | n/m | 0.00 | 2.11 |
| P/B | 0.00 | n/m | 1.78 |
| Price to free cash flow | n/m | n/m | 16.14 |
| EV/EBITDA | 0.97 | n/m | 12.58 |
| EV/Sales | n/m | 6.43 | 2.73 |
| Earnings yield | (73,121.23%) | (127,222.23%) | (4.38%) |
| Free cash flow yield | (95,565.78%) | (246,986.61%) | 0.00% |
Profitability
| Metric | PRFX | RDHL | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 35.16% | 53.94% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 25.20% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 0.00% | (0.40%) |
| Return on assets | 0.00% | 0.00% | (3.32%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack